Azienda Ospedaliero-Universitaria di Parma

Azienda Ospedaliero-Universitaria di Parma is a public body in Parma, Italy that has taken part in 11 EU-funded projects since 2008, receiving €3.3M in EU funding and leading 2 as coordinator.

EU funding received€3.3M
EU projects11
As coordinator2
Running now4
First EU project2008
Latest project2025
CountryItaly
EU registration (PIC)999607117
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Azienda Ospedaliero-Universitaria di Parma's own share of each project, not the project's full budget.

  • Horizon 2020€1.6M · 4 projects
  • FP7 (2007 to 2013)€1.4M · 3 projects
  • Citizens, Equality, Rights and Values Programme (CERV)€161k · 1 project
  • EU4Health Programme (EU4H)€126k · 2 projects
  • Horizon Europe€0 · 1 project

Projects

11 EU-funded projects, newest first. Azienda Ospedaliero-Universitaria di Parma led 2 of them as coordinator. Each links to the official record.

  • NINFA-ADAssociated partner

    Neuropsychiatric Impairments and Neurotransmitter-related Functional Alterations in Alzheimer’s Disease

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

  • JANE-2Associated partner

    Joint Action on Networks of Expertise on Cancer

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €112ktheir share
  • TEHDAS2Associated partner

    Second Joint Action Towards the European Health Data Space

    EU4Health Programme (EU4H) · 2024–2026 · Project on the EU portal ↗

    €15ktheir share
  • VIPROMPartner

    Victim Protection in Medicine – Exploiting practical knowledge of medical staff to enhance the multi-professional contact with victims of domestic violence

    Citizens, Equality, Rights and Values Programme (CERV) · 2023–2026 · Project on the EU portal ↗

    €161ktheir share
  • IP-cure-BAssociated partner

    Immune profiling to guide host-directed interventions to cure HBV infections

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

  • TherVacBPartner

    THERVACB: A THERAPEUTIC VACCINE TO CURE HEPATITIS B

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €715ktheir share
  • BD2DecideCoordinator

    Big Data and models for personalized Head and Neck Cancer Decision support

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €464ktheir share
  • EU-CaREPartner

    A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €394ktheir share
  • FRAILOMICPartner

    Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €441ktheir share
  • HEPACUTEPartner

    Host and viral factors in acute hepatitis C

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €287ktheir share
  • NeoMarkCoordinator

    ICT Enabled Prediction of Cancer Reoccurrence

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €708ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA viruses
  • alzheimer
  • big data
  • cardiovascular diseases
  • eHealth
  • epidemiology
  • head and neck cancer
  • hepatitis B
  • hepatitis C
  • hepatology
  • immunology
  • liver cancer
  • nutrition
  • oncology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime